{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:18:30Z","timestamp":1770513510725,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Janssen Business Technology Commercial Data Sciences"},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s12325-023-02501-5","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T20:53:02Z","timestamp":1680814382000},"page":"2481-2492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension"],"prefix":"10.1007","volume":"40","author":[{"given":"Chang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuen","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeet","family":"Panjabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"issue":"2\u20133","key":"2501_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2040622317693218","volume":"8","author":"JB Badlam","year":"2017","unstructured":"Badlam JB, Bull TM. Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities. Ther Adv Chronic Dis. 2017;8(2\u20133):47\u201364.","journal-title":"Ther Adv Chronic Dis"},{"issue":"9","key":"2501_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221211","volume":"14","author":"E Bergot","year":"2019","unstructured":"Bergot E, De Leotoing L, Bendjenana H, et al. Hospital burden of pulmonary arterial hypertension in France. PLoS ONE. 2019;14(9): e0221211.","journal-title":"PLoS ONE"},{"issue":"5","key":"2501_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1378\/chest.14-0193","volume":"146","author":"CD Burger","year":"2014","unstructured":"Burger CD, Long PK, Shah MR, et al. Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry. Chest. 2014;146(5):1263\u201373.","journal-title":"Chest"},{"issue":"3 Suppl","key":"2501_CR4","first-page":"s47","volume":"21","author":"JP Burke","year":"2015","unstructured":"Burke JP, Hunsche E, R\u00e9gulier E, Nagao M, Buzinec P, Drake W III. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study. Am J Manag Care. 2015;21(3 Suppl):s47-58.","journal-title":"Am J Manag Care"},{"issue":"5","key":"2501_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/11592430-000000000-00000","volume":"9","author":"NY Kirson","year":"2011","unstructured":"Kirson NY, Birnbaum GH, Ivanova JI, Waldman T, Joish V, Williamson T. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population. Appl Health Econ Health Policy. 2011;9(5):293\u2013303.","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"2501_CR6","first-page":"834","volume":"24","author":"CD Burger","year":"2018","unstructured":"Burger CD, Ozbay AB, Lazarus HM, et al. Treatment patterns and associated health care costs before and after treatment initiation among pulmonary arterial hypertension patients in the United States. J Manag Care Spec Pharm. 2018;24(8):834\u201342.","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"2501_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","volume":"55","author":"JB Segal","year":"2017","unstructured":"Segal JB, Chang H-Y, Du Y, Walston JD, Carlson MC, Varadhan R. Development of a claims-based frailty indicator anchored to a well-established frailty phenotype. Med Care. 2017;55(7):716\u201322.","journal-title":"Med Care"},{"issue":"2","key":"2501_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"122","author":"RL Benza","year":"2010","unstructured":"Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010;122(2):164\u201372.","journal-title":"Circulation"},{"issue":"2","key":"2501_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1378\/chest.11-0676","volume":"141","author":"RL Benza","year":"2012","unstructured":"Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012;141(2):354\u201362.","journal-title":"Chest"},{"issue":"2","key":"2501_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies. Chest. 2019;156(2):323\u201337.","journal-title":"Chest"},{"issue":"3","key":"2501_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1183\/09031936.00057010","volume":"36","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Yaici A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36(3):549\u201355.","journal-title":"Eur Respir J"},{"issue":"3","key":"2501_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1183\/09031936.00196611","volume":"40","author":"W-TN Lee","year":"2012","unstructured":"Lee W-TN, Ling Y, Sheares KK, Pepke-Zaba J, Peacock AJ, Johnson MK. Predicting survival in pulmonary arterial hypertension in the UK. Eur Respir J. 2012;40(3):604\u201311.","journal-title":"Eur Respir J"},{"issue":"4","key":"2501_CR13","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e9","year":"2015","unstructured":"Gali\u00e9 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"26","key":"2501_CR14","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","volume":"373","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Channick R, Chin KM, et al. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373(26):2522\u201333.","journal-title":"N Engl J Med"},{"issue":"7","key":"2501_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jacc.2017.12.010","volume":"71","author":"VV McLaughlin","year":"2018","unstructured":"McLaughlin VV, Hoeper MM, Channick RN, et al. Pulmonary arterial hypertension-related morbidity is prognostic for mortality. J Am Coll Cardiol. 2018;71(7):752\u201363.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2501_CR16","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1378\/chest.12-3023","volume":"144","author":"AE Frost","year":"2013","unstructured":"Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, McGoon MD. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(5):1521\u20139.","journal-title":"Chest"},{"issue":"126","key":"2501_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1183\/09059180.00005112","volume":"21","author":"M Humbert","year":"2012","unstructured":"Humbert M, Coghlan JG, Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev. 2012;21(126):306\u201312.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"2501_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S2213-2600(16)00027-8","volume":"4","author":"AC Lajoie","year":"2016","unstructured":"Lajoie AC, Lauzi\u00e8re G, Lega J-C, et al. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis. Lancet Respir Med. 2016;4(4):291\u2013305.","journal-title":"Lancet Respir Med"},{"issue":"12","key":"2501_CR19","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.cjca.2016.03.004","volume":"32","author":"BD Fox","year":"2016","unstructured":"Fox BD, Shtraichman O, Langleben D, Shimony A, Kramer MR. Combination therapy for pulmonary arterial hypertension: a systematic review and meta-analysis. Can J Cardiol. 2016;32(12):1520\u201330.","journal-title":"Can J Cardiol"},{"issue":"1","key":"2501_CR20","doi-asserted-by":"publisher","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","volume":"53","author":"N Gali\u00e8","year":"2019","unstructured":"Gali\u00e8 N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801889.","journal-title":"Eur Respir J"},{"issue":"1","key":"2501_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s41030-019-00106-4","volume":"6","author":"S Studer","year":"2020","unstructured":"Studer S, Hull M, Pruett J, Elliot C, Tsang Y, Drake W III. Retrospective database analysis of treatment patterns among patients with pulmonary arterial hypertension. Pulm Ther. 2020;6(1):79\u201392.","journal-title":"Pulm Ther"},{"issue":"2","key":"2501_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s41030-021-00173-6","volume":"7","author":"A Ogbomo","year":"2021","unstructured":"Ogbomo A, Tsang Y, Kariburyo F, Tsai W-L, Panjabi S. Real-world analysis of treatment patterns among hospitalized patients with pulmonary arterial hypertension. Pulm Ther. 2021;7(2):575\u201390.","journal-title":"Pulm Ther"},{"issue":"1","key":"2501_CR23","doi-asserted-by":"publisher","first-page":"204589401881629","DOI":"10.1177\/2045894018816294","volume":"9","author":"S Studer","year":"2019","unstructured":"Studer S, Hull M, Pruett KE, Tsang Y, Drake III W. Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database. Pulm Circ. 2019;9(1):2045894018816294.","journal-title":"Pulm Circ"},{"issue":"6","key":"2501_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/03007995.2022.2049162","volume":"38","author":"M Gauthier-Loiselle","year":"2022","unstructured":"Gauthier-Loiselle M, Tsang Y, Lefebvre P, et al. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data. Curr Med Res Opin. 2022;38(6):1019\u201330.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"2501_CR25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/ajhp\/zxaa079","volume":"77","author":"AL Martirosov","year":"2020","unstructured":"Martirosov AL, Smith ZR, Hencken L, et al. Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications. Am J Health Syst Pharm. 2020;77(12):958\u201365.","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"2501_CR26","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1513\/AnnalsATS.202005-521OC","volume":"17","author":"JD Lee","year":"2020","unstructured":"Lee JD, Burger CD, Delossantos GB, et al. A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care. Ann Am Thorac Soc. 2020;17(12):1576\u201382.","journal-title":"Ann Am Thorac Soc"},{"key":"2501_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.hjc.2021.10.002","volume":"64","author":"IT Farmakis","year":"2022","unstructured":"Farmakis IT, Karyofyllis P, Frantzeskaki F, et al. Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE). Hellenic J Cardiol. 2022;64:93\u20136.","journal-title":"Hellenic J Cardiol"},{"issue":"5","key":"2501_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/MCP.0000000000000792","volume":"27","author":"TM Cascino","year":"2021","unstructured":"Cascino TM, Desai AA, Kanthi Y. At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease. Curr Opin Pulm Med. 2021;27(5):342\u20139.","journal-title":"Curr Opin Pulm Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02501-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:16:46Z","timestamp":1744715806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["2501"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02501-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}